Detalhe da pesquisa
1.
Interactions Between Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Major Respiratory Viruses in Human Nasal Epithelium.
J Infect Dis;
226(12): 2095-2104, 2022 12 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36031537
2.
Human Respiratory Syncytial Virus-Induced Immune Signature of Infection Revealed by Transcriptome Analysis of Clinical Pediatric Nasopharyngeal Swab Samples.
J Infect Dis;
223(6): 1052-1061, 2021 03 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32726438
3.
The Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4.
J Virol;
93(7)2019 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30651364
4.
Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro.
Biomed Pharmacother;
150: 113058, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35658229
5.
Autoantibodies against type I IFNs in patients with critical influenza pneumonia.
J Exp Med;
219(11)2022 11 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36112363
6.
Avian Cell Line DuckCelt®-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac®.
Vaccines (Basel);
9(10)2021 Oct 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34696298
7.
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
J Exp Med;
218(10)2021 10 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34357402
8.
In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses.
Viruses;
12(10)2020 10 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33049959
9.
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
Antiviral Res;
181: 104878, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32679055
10.
Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model.
Microorganisms;
8(12)2020 Dec 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33322535
11.
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
Cell Rep Med;
1(4): 100059, 2020 07 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32835306
12.
Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy.
Front Immunol;
10: 531, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30941148
13.
SPRi-based hemagglutinin quantitative assay for influenza vaccine production monitoring.
Vaccine;
37(12): 1614-1621, 2019 03 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30773402
14.
Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia.
Sci Rep;
9(1): 11493, 2019 08 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31391513
15.
Strain-Dependent Impact of G and SH Deletions Provide New Insights for Live-Attenuated HMPV Vaccine Development.
Vaccines (Basel);
7(4)2019 Oct 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31671656
16.
Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
Front Immunol;
10: 60, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30761132
17.
Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
J Exp Med;
218(10)2021 Oct 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34415984